1. Home
  2. FTK vs ATXS Comparison

FTK vs ATXS Comparison

Compare FTK & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTK
  • ATXS
  • Stock Information
  • Founded
  • FTK 1985
  • ATXS 2008
  • Country
  • FTK United States
  • ATXS United States
  • Employees
  • FTK N/A
  • ATXS N/A
  • Industry
  • FTK Major Chemicals
  • ATXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTK Industrials
  • ATXS Health Care
  • Exchange
  • FTK Nasdaq
  • ATXS Nasdaq
  • Market Cap
  • FTK 440.6M
  • ATXS 401.2M
  • IPO Year
  • FTK N/A
  • ATXS 2015
  • Fundamental
  • Price
  • FTK $12.64
  • ATXS $6.03
  • Analyst Decision
  • FTK Buy
  • ATXS Strong Buy
  • Analyst Count
  • FTK 2
  • ATXS 7
  • Target Price
  • FTK $12.00
  • ATXS $32.43
  • AVG Volume (30 Days)
  • FTK 751.7K
  • ATXS 310.9K
  • Earning Date
  • FTK 08-05-2025
  • ATXS 08-11-2025
  • Dividend Yield
  • FTK N/A
  • ATXS N/A
  • EPS Growth
  • FTK 683.07
  • ATXS N/A
  • EPS
  • FTK 0.46
  • ATXS N/A
  • Revenue
  • FTK $202,013,000.00
  • ATXS N/A
  • Revenue This Year
  • FTK $15.92
  • ATXS N/A
  • Revenue Next Year
  • FTK $12.67
  • ATXS N/A
  • P/E Ratio
  • FTK $27.89
  • ATXS N/A
  • Revenue Growth
  • FTK 11.96
  • ATXS N/A
  • 52 Week Low
  • FTK $3.79
  • ATXS $3.56
  • 52 Week High
  • FTK $16.87
  • ATXS $12.92
  • Technical
  • Relative Strength Index (RSI)
  • FTK 37.53
  • ATXS 55.45
  • Support Level
  • FTK $12.56
  • ATXS $6.20
  • Resistance Level
  • FTK $13.50
  • ATXS $6.49
  • Average True Range (ATR)
  • FTK 0.62
  • ATXS 0.37
  • MACD
  • FTK -0.25
  • ATXS -0.02
  • Stochastic Oscillator
  • FTK 15.87
  • ATXS 57.06

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: